Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Isradipine

U.S. FDA Requirements: Isradipine

Pharmaceutical / Drug Definition : Inhibits calcium ion movement across cell membranes of cardiac and arterial muscles, relaxing coronary and peripheral vascular smooth muscle. This action reduces diastolic blood pressure, enhances left ventricular function, and improves ejection rates; it also reduces mean vascular and systemic vascular resistance, increasing cardiac output and improving stroke volume.

Registrar Corp assists Isradipine companies with:

  • FDA Registration Isradipine
  • FDA Listing Isradipine
  • FDA Label Requirements and Exceptions Isradipine
  • FDA Import Information Isradipine
  • FDA Detentions Isradipine (Isradipine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Isradipine (Isradipine Suppliers)
       - Processors Isradipine
       - Repackers Isradipine
       - Relabelers Isradipine
       - Exporters Isradipine
       - Importers Isradipine
For more information about Isradipine, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco